4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-021828
Chief Financial Officer sold 282 shares at $29.87 ($8,423)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-03-29 | Sale | −282 | $29.87 | $8,423 | 53,977 | D: show line 1 in the form |
| Open-market sales · 282 sh · avg $29.87 · $8,423 | |||||||
Loading xslF345X03/doc4.xml…